Janhofer Guenter 4
4 · Quince Therapeutics, Inc. · Filed Oct 24, 2023
Insider Transaction Report
Form 4
Janhofer Guenter
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-10-23+300,000→ 300,000 totalExercise: $0.99Exp: 2033-10-22→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent of the shares subject to the stock option vests on the first anniversary of the grant date of October 23, 2023, and the remainder vests in 36 equal monthly installments thereafter for the following three years, subject to the Reporting Person's continuous service as the officer of the Issuer as of each such date.